Physiologic effects of glucagon: Glucagon acts through binding to specific receptors located at the target cell plasma membrane. The major common effect of glucagon is to activate adenylate cyclase and to increase the intracellular production of cAMP. There is considerable evidence that binding of glucagon to its receptor activates an intermediate transduction process that involves the participation of guanosine triphosphate (GTP), divalent cations, and adenosine (or other similar natural substances).
Read More »Dr. Claude Lardinois Part 4 – Interpreting Genetics Testing
Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 4, the final installment of this Exclusive Interview, Dr. Lardinois talks about implementing genetic testing and explains his interpretation of the testing to patients. Dr. Claude Lardinois, M.D., FACP, FACE, …
Read More »Dr. Claude Lardinois Part 3 – Heart Disease and The Genetics Connection
Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 3 of this Exclusive Interview, Dr. Lardinois explains his focus on heart disease over A1C and the connection of genetics in determining risk. Dr. Claude Lardinois, M.D., FACP, FACE, MACN, …
Read More »Dr. Claude Lardinois Part 2 – SGLT-2 and Amputations
Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 2 of this Exclusive Interview, Dr. Lardinois explains his emphasis on the importance of quitting smoking to decrease the risk of amputations. Dr. Claude Lardinois, M.D., FACP, FACE, MACN, has …
Read More »Dr. Claude Lardinois, Part 1 – An Award-Winning Fellow
Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Dr. Lardinois accepts his win as a Fellow of the American College of Endocrinology. Dr. Claude Lardinois, M.D., FACP, FACE, MACN, has been an endocrinologist …
Read More »Claude Lardinois Full Interview
Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. Dr. Lardinois discusses amputations and SGLT-2s, and genetic risk factors for cardiovascular issues in diabetes patients. Dr. Claude Lardinois, M.D., FACP, FACE, MACN, has been an endocrinologist in Reno, Nevada for more …
Read More »Updates on Diabetes Trials, Old and New
Early intervention in treating diabetes has shown long term benefits, follow-up data for both old and new studies show.
Read More »Can Anger and Exercise Trigger a Myocardial Infarction?
International study explores the role of physical exertion, anger, and emotional upset in triggering acute myocardial infarction.
Read More »Prepare Your Patients For An Insulin Change for 2017
Most insurance plans will be dropping Lantus from formularies.
Read More »Low HDL and High Triglycerides Increase Risk of Kidney Disease
These factors are tied to increased nephropathy risk in type 2 diabetes patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.